Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BTX-A vs HA Filler for Excessive Gingival Display
NCT07715331Completed
- Sponsor
- Al-Azhar University
- Start
- Jan 2025
- Primary completion
- Feb 2026
- Countries
- 1
01
Overview
Randomised trial of botulinum toxin type A and hyaluronic acid sodium composite gel for injection in excessive gingival display (2 arms), sponsored by Al-Azhar University. Primary endpoint: Maximum Gingival Display at 6 months. Started Jan 2025; status: completed.
02
Drugs
botulinum toxin type Ahyaluronic acid sodium composite gel for injection
03
Conditions
excessive gingival display
Beyond the preview
Go deeper on NCT07715331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07715331.